{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:12:33Z","timestamp":1762506753554,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA006973"],"award-info":[{"award-number":["P30CA006973"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.urology.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T07:42:37Z","timestamp":1455954157000},"page":"51-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-2627","authenticated-orcid":false,"given":"Mark W.","family":"Ball","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephania M.","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alcides","family":"Chaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila F.","family":"Faraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilda","family":"Gonzalez-Roibon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Munari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trinity J.","family":"Bivalacqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Netto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2016.02.006_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2016.02.006_bib0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/A:1011266405062","article-title":"Risk factors for penile cancer: results of a population-based case\u2013control study in Los Angeles County (United States)","volume":"12","author":"Tseng","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urology.2016.02.006_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/00365590050509913","article-title":"Etiology of squamous cell carcinoma of the penis","volume":"34","author":"Dillner","year":"2000","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1016\/j.urology.2016.02.006_bib0025","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1542\/peds.105.3.e36","article-title":"The highly protective effect of newborn circumcision against invasive penile cancer","volume":"105","author":"Schoen","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.urology.2016.02.006_bib0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.juro.2010.09.111","article-title":"Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma","volume":"185","author":"Thuret","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.006_bib0035","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/1078-0432.CCR-08-1888","article-title":"A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma","volume":"15","author":"Zini","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2016.02.006_bib0040","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.1993.tb16273.x","article-title":"Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis","volume":"72","author":"Ravi","year":"1993","journal-title":"Br J Urol"},{"issue":"suppl 2","key":"10.1016\/j.urology.2016.02.006_bib0045","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1038\/modpathol.2009.26","article-title":"Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications","volume":"22","author":"Amin","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urology.2016.02.006_bib0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00345-008-0275-y","article-title":"Molecular prognostic factors in penile cancer","volume":"27","author":"Muneer","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2016.02.006_bib0055","doi-asserted-by":"crossref","first-page":"1444.e1","DOI":"10.1016\/j.urology.2014.01.028","article-title":"Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy","volume":"83","author":"Gonzalez-Roibon","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.02.006_bib0060","first-page":"2942","article-title":"Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease","volume":"62","author":"Hellawell","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2016.02.006_bib0065","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.humpath.2004.09.005","article-title":"Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis","volume":"35","author":"Shimizu","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urology.2016.02.006_bib0070","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0046-8177(99)90027-8","article-title":"Expression of insulin-like growth factor-1 receptor in human colorectal cancer","volume":"30","author":"Hakam","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urology.2016.02.006_bib0075","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/annonc\/mdp357","article-title":"Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients","volume":"21","author":"Cappuzzo","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urology.2016.02.006_bib0080","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1517\/14728222.9.4.753","article-title":"The insulin-like growth factor-I receptor as a target for cancer therapy","volume":"9","author":"Baserga","year":"2005","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.urology.2016.02.006_bib0085","first-page":"89","article-title":"Practical methods for tissue microarray construction","volume":"103","author":"Fedor","year":"2005","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.urology.2016.02.006_bib0090","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0022-5347(17)41589-8","article-title":"Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results","volume":"140","author":"Catalona","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.006_bib0095","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1200\/JCO.2011.35.2245","article-title":"Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER\/PgR and HER2 testing in breast cancer","volume":"29","author":"Hammond","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2016.02.006_bib0100","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/cncr.26492","article-title":"Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer","volume":"118","author":"Kim","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2016.02.006_bib0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3904\/kjim.2008.23.3.116","article-title":"Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis","volume":"23","author":"Lee","year":"2008","journal-title":"Korean J Intern Med"},{"year":"2010","series-title":"American Joint Committee on Cancer, American Cancer Society: AJCC Cancer Staging Manual","author":"Edge","key":"10.1016\/j.urology.2016.02.006_bib0110"},{"key":"10.1016\/j.urology.2016.02.006_bib0115","first-page":"249","article-title":"The insulin-like growth factor I receptor: a key to tumor growth?","volume":"55","author":"Baserga","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2016.02.006_bib0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1470-2045(02)00731-3","article-title":"Insulin-like growth factors and cancer","volume":"3","author":"Furstenberger","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urology.2016.02.006_bib0125","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ncponc0934","article-title":"Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway\u2014therapeutic perspectives in cancer","volume":"4","author":"Tao","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.urology.2016.02.006_bib0130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urology.2016.02.006_bib0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urology.2016.02.006_bib0140","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.juro.2007.12.040","article-title":"PIK3CA, HRAS and KRAS gene mutations in human penile cancer","volume":"179","author":"Andersson","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.02.006_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.urology.2007.03.003","article-title":"Do proliferating cell nuclear antigen and MIB-1\/Ki-67 have prognostic value in penile squamous cell carcinoma?","volume":"70","author":"Guimar\u00e3es","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.02.006_bib0150","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1359-6446(05)03512-9","article-title":"Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer","volume":"10","author":"Hofmann","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.urology.2016.02.006_bib0155","first-page":"8912","article-title":"A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo","volume":"63","author":"Burtrum","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2016.02.006_bib0160","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2174\/138945011798829401","article-title":"Blockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancers","volume":"12","author":"Rowinsky","year":"2011","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.urology.2016.02.006_bib0165","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1200\/jco.2008.26.15_suppl.3519","article-title":"A phase I, pharmacokinetic (PK) and pharmacodynamic (PD) study of weekly (qW) MK-0646, an insulin-like growth factor-1 receptor (IGF1R) monoclonal antibody (MAb) in patients (pts) with advanced solid tumors","volume":"26","author":"Atzori","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2016.02.006_bib0170","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1200\/jco.2008.26.15_suppl.3520","article-title":"A phase I study of MK-0646, a humanized monoclonal antibody against the insulin-like growth factor receptor type 1 (IGF1R) in advanced solid tumor patients in a q2 wk schedule","volume":"26","author":"Hidalgo","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2016.02.006_bib0175","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2008.17.3567","article-title":"A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers","volume":"26","author":"Camp","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516001424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516001424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T13:15:51Z","timestamp":1620825351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429516001424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":34,"alternative-id":["S0090429516001424"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2016.02.006","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}